BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Sancilio Pharma Release: Altemia Achieves Successful Clinical Results in Pediatric Patients With Sickle Cell Disease

  Statistically significant improvements in markers of coagulation (D-Dimer), inflammation (C-Reactive Protein) and adhesion (E-selectin), key elements associated with the clinical manifestations of SCD, were seen after 8 weeks of treatment.

  November 1, 2017

   · 

  5 min read
• Pharm Country

  Celgene Prices $3 Billion of Senior Unsecured Notes

  Of these notes, $750 million will mature in 2023 and will bear interest at an annual rate of 2.750 percent.

  November 1, 2017

   · 

  4 min read
• Business

  bluebird bio Reports Third Quarter 2017 Financial Results and Recent Operational Progress

  bluebird bio reported business highlights and financial results for the third quarter ended September 30, 2017.

  November 1, 2017

   · 

  13 min read
• Business

  Heska Announces 7-Year Agreement with PetVetCare Centers

  Heska announced today an agreement to supply over 100 PetVetCare veterinary hospitals with in-house laboratory diagnostic equipment and supplies through 2024, which may be extended by the Parties.

  November 1, 2017

   · 

  4 min read
• Policy

  Leading Generics Pharmaceutical Company, Normon Laboratories, Selects TraceLink to Comply with EU FMD Serialization Regulations

  TraceLink today announced that Normon Laboratories, has selected TraceLink’s serialization solutions to comply with the EU Falsified Medicines Directive (FMD) serialization requirements.

  November 1, 2017

   · 

  4 min read
• Business

  Intrexon to Announce Third Quarter 2017 Financial Results on November 9th

  The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update.

  November 1, 2017

   · 

  2 min read
• Business

  Genomic Health to Announce Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017

  The call and webcast will follow the release of the third quarter financial results after market close.

  November 1, 2017

   · 

  2 min read
• Business

  Medizone International Concludes Exclusive Product Supply and License Agreement With Innovasource

  Pursuant to the Supply Agreement, Innovasource will supply its custom-formulated, EPA-registered hydrogen peroxide based disinfectant product to Medizone for use in the AsepticSure Disinfection System.

  November 1, 2017

   · 

  4 min read
• Genetown

  Hologic Launches the MyoSure MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office

  The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products.

  November 1, 2017

   · 

  4 min read
• Genetown

  ImmunoGen to Present New Data on Novel Antibody-Drug Conjugates at 59th ASH Annual Meeting

  ImmunoGen today announced that three abstracts highlighting two of the Company’s experimental ADC therapies, IMGN632 and IMGN779, have been accepted for presentations at the upcoming ASH Annual Meeting to be held December 9-12, 2017, in San Diego.

  November 1, 2017

   · 

  6 min read